INTRODUCTION: Massive hemorrhage remains a major cause of potentially preventable deaths. Better control of bleeding could improve survival rates by 10%-20%. Transfusion intervention concepts have been formulated in order to minimize acute traumatic coagulopathy. These interventions still have not been standardized and vary among medical centers. MATERIALS AND METHODS: Based on a literature search using free term keywords and Medical Subject Heading (MeSH) index, we analyzed published articles addressing massive hemorrhage, component therapy, fresh whole blood, and fibrinogen from the year 2000 onward, in journals with impact factor >1.000, in Medline, PubMed, and Google Scholar. The evidence was grouped into topics including laboratory testing and transfusion interventions/viscoelastic assays vs standard laboratory tests, the effect of component therapy on patient outcome, the effect of warm fresh whole blood on patient outcome, and the effects of fibrinogen in severe bleeding. The obtained information was compared, evaluated, confronted, and was focused on to present an adequate and individual-based massive hemorrhage management approach. RESULTS: Viscoelastic whole-blood assays are superior to standard coagulation blood tests for the identification of coagulopathy and for guiding decisions on appropriate therapy in patients with severe bleeding. Replacement of plasma, red blood cells, platelets, and fibrinogen in a ratio of 1:1:1:1 has appeared to be the best substitution for lost whole blood. There is no evidence that cryoprecipitate improves the outcome of patients with severe hemorrhage. Current literature promotes the transfusion of warm fresh whole blood, which seems to be superior to the component therapy in certain clinical situations. Some authors recommend that fibrinogen and other coagulation factors be administered according to the viscoelastic attributes of the blood clot. CONCLUSION: This best-evidence topic report brings comprehensive information about massive hemorrhage management.

Department of Anesthesiology and Intensive Care Medicine 2nd Faculty of Medicine Charles University University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

Holcomb JB, McMullin NR, Pearse L, et al. Cause of death in U.S. Special Operations Forces in the global war on terrorism: 2001–2004. Ann Surg. 2007;245(6):986–991. PubMed PMC

Grottke O, Fries D, Nascimento B. Perioperatively acquired disorders of coagulation. Curr Opin Anaesthesiol. 2015;28(2):113–122. PubMed PMC

Hayakawa M, Gando S, Ono Y, Wada T, Yanagida Y, Sawamura A. Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study. Semin Thromb Hemost. 2015;41(1):35–42. PubMed

Khan S, Davenport R, Raza I, et al. Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med. 2015;41(2):239–247. PubMed

Deras P, Villiet M, Manzanera J, et al. Early coagulopathy at hospital admission predicts initial or delayed fibrinogen deficit in severe trauma patients. J Trauma Acute Care Surg. 2014;77(3):433–440. PubMed

Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma. 2008;65(4):951–960. PubMed

Cohen MJ, Kutcher M, Redick B, et al. PROMMTT Study Group Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care Surg. 2013;75(1 Suppl 1):S40–S47. PubMed PMC

McQuilten ZK, Crighton G, Engelbrecht S, et al. Transfusion interventions in critical bleeding requiring massive transfusion: a systematic review. Transfus Med Rev. 2015;29(2):127–137. PubMed

Schöchl H, Maegele M, Solomon C, Görlinger K, Voelckel W. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med. 2012;20:15. PubMed PMC

Hagemo JS, Christiaans SC, Stanworth SJ, et al. Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study. Crit Care. 2015;19:97. PubMed PMC

Moore HB, Moore EE, Chin TL, et al. Activated clotting time of thrombelastography (T-ACT) predicts early postinjury blood component transfusion beyond plasma. Surgery. 2014;156(3):564–569. PubMed PMC

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv. 2012;67(7):426–435. PubMed

de Lange NM, van Rheenen-Flach LE, Lancé MD, et al. Peri-partum reference ranges for ROTEM(R) thromboelastometry. Br J Anaesth. 2014;112(5):852–859. PubMed

Tanaka KA, Mazeffi M, Durila M. Role of prothrombin complex concentrate in perioperative coagulation therapy. J Intensive Care. 2014;2(1):60. PubMed PMC

Stansbury LG, Hess JR. Blood transfusion in World War I: the roles of Lawrence Bruce Robertson and Oswald Hope Robertson in the “most important medical advance of the war”. Transfus Med Rev. 2009;23(3):232–336. PubMed

Churchill ED. The surgical management of the wounded in the Mediterranean Theater at the time of fall of Rome. Ann Surg. 1944;120(3):268–283. PubMed PMC

Miller TE. New evidence in trauma resuscitation – is 1:1:1 the answer? Perioper Med (Lond) 2013;2(1):13. PubMed PMC

National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564–2575. PubMed

Cotton BA, Guys JS, Morris JA, Jr, Abumrad NN. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock. 2006;26(2):115–121. PubMed

Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63(4):805–813. PubMed

Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma. 2008;64(2 Suppl):S79–S85. PubMed

Spinella PC. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Crit Care Med. 2008;36(7 Suppl):S340–S345. PubMed

Van PY, Sambasivan CN, Wade CE, et al. High transfusion ratios are not associated with increased complication rates in patients with severe extremity injuries. J Trauma. 2010;69(Suppl 1):S64–S68. PubMed

Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248(3):447–458. PubMed

Shaz BH, Dente CJ, Nicholas J, et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion. 2010;50(2):493–500. PubMed

Hall S, Murphy MF. Limitations of component therapy for massive haemorrhage: is whole blood the whole solution? Anaesthesia. 2015;70(5):511–514. PubMed

Wilkinson KL, Brunskill SJ, Dorée C, et al. The clinical effects of red blood cell transfusions: an overview of the randomized controlled trials evidence base. Transfus Med Rev. 2011;25(2):145–155. PubMed

Lacroix J, Hébert PC, Fergusson DA, et al. ABLE Investigators. Canadian Critical Care Trials Group Age of transfused blood in critically ill adults. N Engl J Med. 2015;372(15):1410–1418. PubMed

Pettilä V, Westbrook AJ, Nichol AD, et al. Blood Observational Study Investigators for ANZICS Clinical Trials Group Age of red blood cells and mortality in the critically ill. Crit Care. 2011;15(2):R116. PubMed PMC

Aubron C, Nichol A, Cooper DJ, Bellomo R. Age of red blood cells and transfusion in critically ill patients. Ann Intensive Care. 2013;3(1):2. PubMed PMC

Blake JT, Hardy M, Delage G, Myhal G. Déjà-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Héma-Québec. Transfusion. 2013;53(7):1544–1558. PubMed

Dumont LJ, AuBuchon JP, Whitley P, et al. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion. 2002;42(7):847–854. PubMed

Inaba K, Branco BC, Rhee P, et al. Impact of the duration of platelet storage in critically ill trauma patients. J Trauma. 2011;71(6):1766–1773. PubMed

Pereboom IT, de Boer MT, Haagsma EB, Hendriks HG, Lisman T, Porte RJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg. 2009;108(4):1083–1091. PubMed

Sørensen B, Tang M, Larsen OH, Laursen PN, Fenger-Eriksen C, Rea CJ. The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding. Thromb Res. 2011;128(Suppl 1):S13–S16. PubMed

Gregory JA, Huitron SS, George AA, Simon CD. Optimizing Transfusion Ratios in Massive Transfusion Protocols: An Argument Against the 1:1:1 Dogma and Approach to Trauma Resuscitation. Lab Med. 2015;46(2):46–52. PubMed

Yamamoto K, Usui A, Takamatsu J. Fibrinogen concentrate administration attributes to significant reductions of blood loss and transfusion requirements in thoracic aneurysm repair. J Cardiothorac Surg. 2014;9:90. PubMed PMC

Hannon M, Quail J, Johnson M, et al. Fibrinogen and prothrombin complex concentrate in trauma coagulopathy. J Surg Res. 2015;196(2):368–372. PubMed

Farrugia A, Vamvakas E. Toward a patient-based paradigm for blood transfusion. J Blood Med. 2014;5:5–13. PubMed PMC

Vamvakas EC. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice. Transfusion. 2013;53(4):888–901. PubMed

Davies RL. Should whole blood replace the shock pack? J R Army Med Corps. Epub 2015 Mar 27. PubMed

Weiskopf RB. Reconstructing deconstructed blood for trauma. Anesthesiology. 2012;116(3):518–521. PubMed

Olaussen A, Fitzgerald MC, Tan GA, Mitra B. Cryoprecipitate administration after trauma. Eur J Emerg Med. Epub 2015 Mar 2. PubMed

Durila M, Lukáš P, Astraverkhava M, Vymazal T. Evaluation of fibrinogen concentrates and prothrombin complex concentrates on coagulation changes in a hypothermic in vitro model using thromboelastometry and thromboelastography. Scand J Clin Lab Invest. 2015;75(5):407–414. PubMed

Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60(6 Suppl):S3–S11. PubMed

Bruckner BA, Blau LN, Rodriguez L, et al. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures. J Cardiothorac Surg. 2014;9:134. PubMed PMC

Gabay M. Absorbable hemostatic agents. Am J Health Syst Pharm. 2006;63(13):1244–1253. PubMed

Romanò CL, Monti L, Logoluso N, Romanò D, Drago L. Does a thrombin-based topical haemostatic agent reduce blood loss and transfusion requirements after total knee revision surgery? A randomized, controlled trial. Knee Surg Sports Traumatol Arthrosc. 2014 PubMed

Zhuang B, Li Z, Pang J, et al. Nanocomplexation of thrombin with cationic amylose derivative for improved stability and hemostatic efficacy. Int J Nanomedicine. 2015;10:939–947. PubMed PMC

Rotational Thromboelastometry Helps to Reduce Blood Product Consumption in Critically Ill Patients during Small Surgical Procedures at the Intensive Care Unit - a Retrospective Clinical Analysis and Literature Search

Direct thrombolysis of multiple thrombi in both right and left heart atrium in a patient on extracorporeal membrane oxygenation support following urgent double-lung transplantation: a case report